CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 20,000 shares, an increase of 35.1% from the November 30th total of 14,800 shares. Based on an average daily volume of 400 shares, the days-to-cover ratio is presently 50.0 days.

CanSino Biologics Stock Performance

Shares of OTCMKTS:CASBF remained flat at C$3.75 during midday trading on Friday. 50 shares of the stock traded hands, compared to its average volume of 1,389. The stock has a fifty day moving average price of C$3.86 and a 200-day moving average price of C$3.02. CanSino Biologics has a one year low of C$1.86 and a one year high of C$4.35.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.